Adalimumab in the treatment of cardiac sarcoidosis: Single center case series and narrative literature review

BACKGROUND: Tumor necrosis factor (TNF) inhibitors have been used in the treatment of cardiac sarcoidosis, infliximab being the most commonly used. We have previously reported a case of effective treatment of cardiac sarcoidosis using adalimumab. OBJECTIVE: To describe our experience of using adalim...

Descripción completa

Detalles Bibliográficos
Autores principales: Sweis, Jaleel Jerry G., Sweis, Nabil William G., Ascoli, Christian, Levin, Benjamin, Avitall, Boaz, Rubinstein, Israel, Kondos, George, Culver, Daniel A., Judson, Marc, Baughman, Robert, Darbar, Dawood, Drake, Wonder, Shahrara, Shiva, Cooper, Leslie T., Sweiss, Nadera J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627097/
https://www.ncbi.nlm.nih.gov/pubmed/36340865
http://dx.doi.org/10.1016/j.rmcr.2022.101766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627097/
https://www.ncbi.nlm.nih.gov/pubmed/36340865
http://dx.doi.org/10.1016/j.rmcr.2022.101766

Ejemplares similares